Filing Details
- Accession Number:
- 0001567619-21-019740
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-10 17:31:41
- Reporting Period:
- 2021-11-08
- Accepted Time:
- 2021-11-10 17:31:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219445 | P Brian Mckeon | One Idexx Drive Westbrook ME 04092 | Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-08 | 10,000 | $67.85 | 36,317 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-08 | 1,300 | $625.25 | 35,017 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-08 | 1,100 | $626.47 | 33,917 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-08 | 1,326 | $627.41 | 32,591 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-08 | 2,356 | $628.19 | 30,235 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-08 | 2,094 | $629.63 | 28,141 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-08 | 971 | $630.39 | 27,170 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-08 | 743 | $631.39 | 26,427 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-08 | 110 | $632.19 | 26,317 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-11-09 | 6,310 | $67.85 | 32,627 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-09 | 5,703 | $630.13 | 26,924 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-09 | 607 | $631.01 | 26,317 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-11-08 | 10,000 | $0.00 | 10,000 | $67.85 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2021-11-09 | 6,310 | $0.00 | 6,310 | $67.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 35,535 | 2026-02-13 | No | 4 | M | Direct | |
| 29,225 | 2026-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 18,050 | Indirect | by Estony McKeon Family, LLC |
Footnotes
- Includes 9 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2021.
- This transaction was executed in multiple trades at prices ranging from $625.00 to $625.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $626.10 to $627.005. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $627.07 to $628.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $628.01 to $628.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $629.10 to $629.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $630.03 to $630.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $631.10 to $631.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $632.01 to $632.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $630.00 to $631.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $631.005 to $631.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Grant of option to buy 45,535 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017.
- Not applicable.
Billionaire Hedge Funds
